Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical pharmacology and therapy

• Publication date

  2005-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.clpt.2004.10.011PMID 15735609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The scientific case that nicotine is addictive

  2005cited by this paper
• Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method.

  2005cited by this paper
• Pathological gambling: a comprehensive review of biobehavioral findings.

  2004cited by this paper
• A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men.

  2004cited by this paper
• Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

  2004influential reference
• A meta-analytic review of the CYP2A6 genotype and smoking behavior.

  2004cited by this paper
• Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.

  2004cited by this paper
• Meanings of smoking and adolescent smoking across ethnicities.

  2004cited by this paper
• Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers

  2004cited by this paper
• Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice

  2004cited by this paper
• Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats

  2004cited by this paper
• Evidence of Association between Smoking and α7 Nicotinic Receptor Subunit Gene in Schizophrenia Patients

  2004cited by this paper
• Interindividual variability of coumarin 7-hydroxylation in a Turkish population

  2004cited by this paper
• Recollections and repercussions of the first inhaled cigarette.

  2004cited by this paper
• Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity

  2004cited by this paper
• Motivational influences on cigarette smoking.

  2004cited by this paper
• Why people smoke

  2004cited by this paper
• Whole Deletion of CYP2A6 Gene (CYP2A6*4C) and Smoking Behavior

  2004cited by this paper
• Genetics of alcohol and tobacco use in humans

  2003influential reference
• Decreasing smoking behaviour and risk through CYP2A6 inhibition.

  2003cited by this paper
• Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9).

  2003cited by this paper
• Elucidating the role of genetic factors in smoking behavior and nicotine dependence

  2003cited by this paper
• Short-Term Adolescent Nicotine Exposure has Immediate and Persistent Effects on Cholinergic Systems: Critical Periods, Patterns of Exposure, Dose Thresholds

  2003cited by this paper
• Estimates of global mortality attributable to smoking in 2000.

  2003cited by this paper
• Effects of polymorphism in Promoter Region of Human CYP2A6 Gene (CYP2A6*9) on Expression Level of Messenger Ribonucleic Acid and Enzymatic Activity In Vivo and In Vitro

  2003cited by this paper
• Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.

  2003cited by this paper
• Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in peripheral human lung microsomes.

  2003cited by this paper
• Nicotine metabolite ratio as a predictor of cigarette consumption.

  2003cited by this paper
• The meanings of smoking among Chinese American and Taiwanese American college students.

  2003cited by this paper
• The genetic determinants of smoking.

  2003cited by this paper
• A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population

  2003cited by this paper
• Nicotine as a modulator of behavior: beyond the inverted U.

  2003cited by this paper
• Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor Autoradiography

  2003cited by this paper
• Association of CYP2A6 Gene Deletion with Cigarette Smoking Status in Japanese Adults

  2003cited by this paper
• Evidence for Enhanced Neurobehavioral Vulnerability to Nicotine during Periadolescence in Rats

  2003cited by this paper
• Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice.

  2003cited by this paper
• Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors

  2003cited by this paper
• The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.

  2003cited by this paper
• Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema

  2003cited by this paper
• Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area

  2003cited by this paper
• Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity

  2002cited by this paper
• A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur.

  2002cited by this paper
• Genetic and functional analysis of single nucleotide polymorphisms in the beta2-neuronal nicotinic acetylcholine receptor gene (CHRNB2).

  2002cited by this paper
• Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.

  2002cited by this paper
• Applying genetic approaches to the treatment of nicotine dependence

  2002cited by this paper
• An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles.

  2002cited by this paper
• Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism.

  2002cited by this paper
• Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal

  2002cited by this paper
• Nicotine addiction: the possible role of functional upregulation.

  2002cited by this paper
• CYP2A6 genetic variation and potential consequences.

  2002cited by this paper
• Nicotine-induced conditioned place preference in adolescent and adult rats.

  2002cited by this paper
• Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking.

  2001cited by this paper
• Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: impairment of its promoter activity.

  2001cited by this paper
• Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method.

  2001cited by this paper
• CYP2A6*6, a Novel Polymorphism in Cytochrome P450 2A6, Has a Single Amino Acid Substitution (R128Q) That Inactivates Enzymatic Activity*

  2001cited by this paper
• Molecular and Physiological Diversity of Nicotinic Acetylcholine Receptors in the Midbrain Dopaminergic Nuclei

  2001cited by this paper
• Nicotine metabolism and CYP2A6 allele frequencies in Koreans.

  2001cited by this paper
• Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans

  2001cited by this paper
• A novel single nucleotide polymorphism altering stability and activity of CYP2a6.

  2001cited by this paper
• Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk.

  2001cited by this paper
• Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms.

  2001cited by this paper
• Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population

  2001cited by this paper
• Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.

  2001cited by this paper
• Reward deficiency syndrome: genetic aspects of behavioral disorders.

  2000cited by this paper
• Stages in the development of adolescent smoking.

  2000cited by this paper
• Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.

  2000cited by this paper
• Initial symptoms of nicotine dependence in adolescents

  2000cited by this paper
• High levels of dopamine activity in the basal ganglia of cigarette smokers.

  2000cited by this paper
• Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies

  2000cited by this paper
• Neurobiology of Addiction: Toward the Development of New Therapies

  2000cited by this paper
• Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans

  2000cited by this paper
• Polymorphisms in genes involved in neurotransmission in relation to smoking.

  2000cited by this paper
• Mimicking Gene Defects to Treat Drug Dependence

  2000cited by this paper
• CYP2A6: a human coumarin 7-hydroxylase.

  2000cited by this paper
• Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking

  2000cited by this paper
• Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.

  2000cited by this paper
• Nicotine blood levels and subjective craving for cigarettes.

  2000cited by this paper
• Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C.

  2000cited by this paper
• The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit

  2000cited by this paper
• Predicting smoking cessation and major depression in nicotine-dependent smokers.

  2000cited by this paper
• An Improved Assay Shows No Association Between the CYP2A6 Gene and Cigarette Smoking Behavior

  1999cited by this paper
• Genetic polymorphism of CYP2A6 in relation to cancer.

  1999cited by this paper
• Genetic and Social Determinants of Initiation and Age at Onset of Smoking in Australian Twins

  1999cited by this paper
• Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies.

  1999cited by this paper
• CYP2A6 gene deletion reduces susceptibility to lung cancer.

  1999cited by this paper
• The Genetics of Smoking Persistence in Men and Women: A Multicultural Study

  1999cited by this paper
• The genetic epidemiology of smoking.

  1999cited by this paper
• Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism

  1999cited by this paper
• Characterisation and PCR‐based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population

  1999cited by this paper
• Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method.

  1999cited by this paper
• Genetic variation of CYP2A6, smoking, and risk of cancer.

  1999cited by this paper
• Nicotine withdrawal in the rat: role of alpha7 nicotinic receptors in the ventral tegmental area.

  1999cited by this paper
• Genetic variation of CYP2A6, smoking, and risk of cancer

  1999cited by this paper
• A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride in humans.

  1999cited by this paper
• The Genetics of Smoking Initiation and Quantity Smoked in Dutch Adolescent and Young Adult Twins

  1999cited by this paper
• Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine

  1998cited by this paper
• Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C‐oxidase

  1998cited by this paper
• A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502).

  1998cited by this paper
• Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6

  1998cited by this paper
• Dramatic decreases in brain reward function during nicotine withdrawal

  1998cited by this paper

• Serum nicotine metabolite profiles and their association with hematological, biochemical, and cardiovascular parameters in smokers

  2026cites this paper
• Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community

  2025cites this paper
• A blind spot in fMRI research: Overlooked tobacco smoking-related confounds

  2025cites this paper
• Inhibition of CYP2A6-mediated nicotine metabolism: A potential strategy for smoking cessation therapy.

  2025cites this paper
• The Role of Genetics in Stroke Risk and Outcome: A Review of Current Evidence

  2025cites this paper
• Efficacy of varenicline or bupropion and its association with nicotine metabolite ratio among smokers with COPD

  2024cites this paper
• Role of Cytochrome P450 3A4 in Cancer Drug Resistance: Challenges and Opportunities.

  2024cites this paper
• Evidence for sex differences in the impact of cytochrome P450 genotypes on early subjective effects of cannabis.

  2024cites this paper
• Metabolism-dependent mutagenicity of two structurally similar tobacco-specific nitrosamines (N-nitrosonornicotine and N-nitrosoanabasine) in human cells, partially different CYPs being activating enzymes.

  2024cites this paper
• Rauchen – Wissenswertes über Tabak und alternative Produkte

  2023cites this paper
• Physiologic Effects of Substance Use.

  2023cites this paper
• RISK REDUCTION ASSESSMENT: EPIDEMIOLOGY AND NOVEL APPROACHES

  2023cites this paper
• Advice for smokers in smoking cessation clinic: a review

  2023cites this paper
• Evaluation of Adult Attention Deficit and Hyperactivity Disorder in Smoking Doctors

  2023cites this paper
• Biochemical and genetic biomarkers associated with nicotine dependence in Mexican smokers

  2023cites this paper
• Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant ‐ implications for precision dosing in a global perspective

  2022cites this paper
• Associations of genetic risk, BMI trajectories, and the risk of non-small cell lung cancer: a population-based cohort study

  2022cites this paper
• Multi-trait genome-wide association analyses leveraging alcohol use disorder findings identify novel loci for smoking behaviors in the Million Veteran Program

  2022cites this paper
• Molecular and Spectroscopic Evaluation of the Effects of Coumarin on Lentil

  2021cites this paper
• How to manage cigarette smoking in kidney transplant candidates and recipients?

  2021cites this paper
• A Multi-Disciplinary Study into the Drivers of Smoking Cessation in Australia

  2020cites this paper
• Association between CYP2A6 genotypes and smoking behavior in Lebanese smokers

  2020cites this paper
• Structure–activity relationship and in vitro inhibition of human cytochrome CYP2A6 and CYP2A13 by flavonoids

  2020cites this paper
• Epigenetic Profiling of Obesity and Smoking

  2020cites this paper
• Oncogenomics and CYP450 Implications in Personalized Cancer Therapy

  2020cites this paper
• Nicotine Metabolism in Adults With Type 2 Diabetes.

  2019cites this paper
• Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019; 163:XX

  2019cites this paper
• Facteurs de risque comportementaux

  2019cites this paper
• Nicotine Pharmacokinetics in Rat Brain and Blood by Simultaneous Microdialysis, Stable-Isotope Labeling, and UHPLC-HRMS: Determination of Nicotine Metabolites.

  2019cites this paper
• Principles of Pharmacogenomics

  2019cites this paper
• SNPs within CHRNA5-A3-B4 and CYP2A6/B6, nicotine metabolite concentrations and nicotine dependence treatment success in smokers.

  2019cites this paper
• Pharmacogenomics of nicotine metabolism: novel CYP2A6 and CYP2B6 genetic variation patterns in Alaska Native and American Indian populations.

  2019cites this paper
• Considering Genetic Heterogeneity in the Association Analysis Finds Genes Associated With Nicotine Dependence

  2019cites this paper
• Preparing the Way: Exploiting Genomic Medicine to Stop Smoking.

  2018cites this paper
• Nicotinic acetylcholine receptor gene polymorphism is not associated with tobacco-related oral squamous cell carcinoma.

  2018cites this paper
• CYP2A6 metabolism in the development of smoking behaviors in young adults

  2018influential citation
• Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population

  2018cites this paper
• CYP2A6 gene variants may explain smoking status in a Turkish cohort

  2018cites this paper
• Analytical Studies on the Impact of Smoking Cessation on the Metabolic Profile

  2018cites this paper
• Genomics and Drug-Metabolizing Enzymes and Its Application in Drug Delivery: Evaluating the Influence of the Microbiome

  2018cites this paper
• Genetics, Behavior, and Behavior-Genetic Interactions in Health Risk

  2018cites this paper
• Airborne Nicotine, Secondhand Smoke, and Precursors to Adolescent Smoking

  2018cites this paper
• Tobacco biomarkers and genetic/epigenetic analysis to investigate ethnic/racial differences in lung cancer risk among smokers

  2018cites this paper
• Brain substrates of early (4h) cigarette abstinence: Identification of treatment targets.

  2018cites this paper
• Circadian Regulation of Hepatic Cytochrome P450 2a5 by Peroxisome Proliferator-Activated Receptor γ

  2018cites this paper
• Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction

  2017influential citation
• Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages.

  2017cites this paper
• GRONS: a comprehensive genetic resource of nicotine and smoking

  2017cites this paper
• Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer

  2017cites this paper
• Nicotine , carcinogen and toxicant exposure in long-term e-cigarette and nicotine replacement therapy users : a cross-sectional study Running title : e-cigarettes and toxicant exposure

  2017cites this paper
• A Clinical Overview of Nicotine Dependence and Withdrawal

  2017cites this paper
• Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users

  2017cites this paper
• Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.

  2017cites this paper
• Title Comprehensive evaluation of variability in nicotine metabolism andCYP 2 A 6 polymorphic alleles in four ethnic populations

  2017cites this paper
• Evaluating the Real-World Effectiveness of Bupropion Versus Varenicline for Smoking Cessation: Exploring the Role of Nicotine Metabolism and Medication Adherence

  2017cites this paper
• Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans

  2017cites this paper
• Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors

  2017cites this paper
• in long-term e-cigarette and replacement therapy

  2017cites this paper
• Maternal Smoking during Pregnancy and Necrotizing Enterocolitis-associated Infant Mortality in Preterm Babies

  2017cites this paper
• Nicotine Dependence – Identifying the Contribution of Specific Genes

  2017cites this paper
• A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems

  2016cites this paper
• Prevalence and impact of long-term use of nicotine replacement therapy in UK stop-smoking services: findings from the ELONS study. Nicotine and

  2016cites this paper
• Refining Associations between Targeted Genes and the Development of Substance Use Disorders

  2016cites this paper
• Genetic Aspects of Smoking Behavior in the Japanese Population

  2016cites this paper
• CYP2A6 Longitudinal Effects in Young Smokers.

  2016cites this paper
• Effectiveness of Standard vs Individualized Treatment on Smoking Cessation and Cue Reactivity: An fMRI Study

  2016cites this paper
• Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity

  2016cites this paper
• Role of pharmacogenetics for the improvement of cancer treatment

  2016cites this paper
• CYP2A6 Effects on Subjective Reactions to Initial Smoking Attempt.

  2016cites this paper
• Impact of the interactions of CYP2B6*6 and CYP2A6 Polymorphisms on the treatment of nicotine dependence

  2016cites this paper
• Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking.

  2016cites this paper
• Prevalence and Impact of Long-term Use of Nicotine Replacement Therapy in UK Stop-Smoking Services: Findings From the ELONS Study

  2016cites this paper
• Simultaneous determination of nicotine and its nine metabolites in rat blood utilizing microdialysis coupled with UPLC–tandem mass spectrometry for pharmacokinetic application

  2015cites this paper
• Predictors of the nicotine reinforcement threshold, compensation, and elasticity of demand in a rodent model of nicotine reduction policy.

  2015cites this paper
• Cytochrome P450 in Cancer Susceptibility and Treatment.

  2015cites this paper
• Does ethnic ancestry play a role in smoking?

  2015cites this paper
• Drug Metabolism, Transport, and Pharmacogenomics

  2015cites this paper
• Evaluating Long-term Outcomes of NHS Stop Smoking Services (ELONS): a prospective cohort study.

  2015cites this paper
• Variation in Nicotine and Nitrosamine Pharmacology Genes and Smoking-associated Lung Cancer

  2015cites this paper
• [Association between genotype and allele frequencies of CYP2A6*12 and rs16969968 in CHRNA5 variants with smoking and body mass index in young subjects from Northeast Mexico].

  2015cites this paper
• Pharmacogenetics of nicotine and associated smoking behaviors.

  2015cites this paper
• CNVs Associated with Susceptibility to Cancers: A Mini-Review

  2015cites this paper
• Smoking-Related Genes and Functional Consequences

  2014cites this paper
• Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitor.

  2014cites this paper
• Drug abuse and the neurovascular unit.

  2014cites this paper
• An examination of the relationships between causal attributions for smoking and smokers' treatment seeking and quit intentions: A structural equation modeling approach

  2014cites this paper
• Running head: NICOTINE BIOMARKERS IN DAILY AND NONDAILY SMOKERS A Comparison of Nicotine Biomarkers and Smoking Patterns in Daily and Non-daily Smokers

  2014cites this paper
• Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo

  2014cites this paper
• Electrochemical detection of human cytochrome P450 2A6 inhibition: a step toward reducing dependence on smoking.

  2014cites this paper
• The Pharmacogenetics of Nicotine Dependence and Smoking Cessation Therapies

  2014cites this paper
• Genetics of Nicotine Addiction

  2014cites this paper
• Cytochrome P450 Polymorphisms of Clinical Importance

  2014cites this paper
• A Comparison of Nicotine Biomarkers and Smoking Patterns in Daily and Nondaily Smokers

  2014cites this paper
• Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms.

  2014cites this paper
• Through the smoke: use of in vivo and in vitro cigarette smoking models to elucidate its effect on female fertility.

  2014cites this paper
• Efficacy of S-1 in non-small cell lung cancer

  2014cites this paper
• Finding genomic function for genetic associations in nicotine addiction research: the ENCODE project's role in future pharmacogenomic analysis.

  2014cites this paper
• Where there is smoke, there is risk: Social and pharmacological exposure to smoking increase risk for smoking behavior during adolescence

  2014cites this paper
• The Interaction Between Genetics and Tobacco Consumption in Light Smokers

  2014cites this paper
• Re-defininG AddiCCH3Tion: genomics and epigenomics on substance use disorders

  2014cites this paper